1. Home
  2. MCI vs FTRE Comparison

MCI vs FTRE Comparison

Compare MCI & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCI
  • FTRE
  • Stock Information
  • Founded
  • MCI 1971
  • FTRE 1996
  • Country
  • MCI United States
  • FTRE United States
  • Employees
  • MCI N/A
  • FTRE N/A
  • Industry
  • MCI Trusts Except Educational Religious and Charitable
  • FTRE Medical Specialities
  • Sector
  • MCI Finance
  • FTRE Health Care
  • Exchange
  • MCI Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • MCI 419.4M
  • FTRE 468.1M
  • IPO Year
  • MCI N/A
  • FTRE N/A
  • Fundamental
  • Price
  • MCI $20.51
  • FTRE $6.58
  • Analyst Decision
  • MCI
  • FTRE Hold
  • Analyst Count
  • MCI 0
  • FTRE 11
  • Target Price
  • MCI N/A
  • FTRE $14.70
  • AVG Volume (30 Days)
  • MCI 40.4K
  • FTRE 2.0M
  • Earning Date
  • MCI 01-01-0001
  • FTRE 08-06-2025
  • Dividend Yield
  • MCI 8.46%
  • FTRE N/A
  • EPS Growth
  • MCI N/A
  • FTRE N/A
  • EPS
  • MCI 1.82
  • FTRE N/A
  • Revenue
  • MCI N/A
  • FTRE $2,733,500,000.00
  • Revenue This Year
  • MCI N/A
  • FTRE N/A
  • Revenue Next Year
  • MCI N/A
  • FTRE $0.97
  • P/E Ratio
  • MCI $9.88
  • FTRE N/A
  • Revenue Growth
  • MCI N/A
  • FTRE N/A
  • 52 Week Low
  • MCI $12.96
  • FTRE $3.97
  • 52 Week High
  • MCI $19.24
  • FTRE $25.74
  • Technical
  • Relative Strength Index (RSI)
  • MCI 43.73
  • FTRE 57.15
  • Support Level
  • MCI $20.00
  • FTRE $5.82
  • Resistance Level
  • MCI $20.83
  • FTRE $7.98
  • Average True Range (ATR)
  • MCI 0.47
  • FTRE 0.76
  • MACD
  • MCI -0.07
  • FTRE 0.08
  • Stochastic Oscillator
  • MCI 42.73
  • FTRE 54.10

About MCI Barings Corporate Investors

Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: